An interesting week which saw the nearest thing to a Santa Rally on good
inflation news. Unfortunately there's still no sign of an update from
OPTI:Optibiotix so the share price dropped 1p. Normally that would have
put me deep in the red, but a 21% increase in
JLP:Jubilee Metals despite announcing a discounted placing countered the drop and I ended up
pretty flat with the deficit between cost and value improving by £165 to £94,653
despite me taking some profits, and overall portfolio value increasing to
£110,107.
KIBO:Kibo Energy was the worst performer dropping 13%, but it's 13% of
nothing so no worries.
IES:Invinity Energy dropped 7% which is disappointing as they looked
like they were on the way back up. At 27p to buy on the market, I decided to
let my 50p warrants expire this week.
One of my holdings in JLP:Jubilee Metals dropped 6%. This was a
purchase just after the announcement of a new joint venture that should be a
game changer for the company, so I bought a load at 6.7p. After assuring
shareholders in the past that there would be no more dilution I figured this
was a bargain. Two days later they announced a placing at 5.5p. I can
understand their reasoning for the placing, but I find it unforgivable that
they didn't announce the placing at the same time as the new joint venture. On
Friday morning the share price dropped close to 5.5p and I was spitting
feathers. It did recover in the afternoon but I was still 6% down in one day.
Hopefully this won't matter next week, but I feel let down by what seems like
a dirty trick for those in the know to sell into the rise after the joint
venture news knowing they could buy back cheaper on Friday morning. "Legally
crooked" is the phrase used in a book I'm currently reading.
Onto the good news. CAML:Cental Asia Metals went up by 6% and put
one of my holdings into profit. The rest are still down, but if metal prices
don't drop then hopefully there can be a sustained rise. With a P/E ratio of
just 9.5, these have plenty of room for improvement.
GAW:Games Workshop recovered from last week's big drop and went up by
7% putting my original holding 1% into profit, and my new holding 3% into
profit. Happy days.
ASHM:Ashmore Group have been flying, and went up another 8% this week.
They are still 24% down, but it means I can change their colour to orange from
orange-red.
FXPO:Ferrexpo also went up 8%. I don't think they will re-rate until
the war in Ukraine is over, and they are still 84% down, but things could be a
lot worse and we can just keep hoping they remain safe.
SAE:Simec Atlantis Energy have been quite volatile lately. They went
up 10% this week, but I don't hold out much hope of them ever recovering, and
in my mind have written them off, but not yet on my balance sheet.
Share of the Week goes to my original holding in
JLP:Jubilee Metals which went up 21% after the announcement of the
joint venture. The potential income from this alone dwarfs anything we already
produce, and this is just a start. There are piles of slag all over the world,
and we now have a capital-rich partner to help secure it. I have 247,451
shares, which is more than I have in OPTI:Optibiotix, although they
didn't cost as much. They did cost £21,259 though, so it's by far my biggest
holding other than OPTI. Given I've already made £18,849 profit from my
previous holdings in JLP, they have been my most successful investment.
I hope the curse that tends to fall on most companies I buy doesn't fall on
these!
Here's the ISA and shares portfolio after week 20 of year 9.
|
|
|
Weekly Change |
| Cash |
£140.10 |
|
-£65.82 |
| Portfolio cost |
£99,175.93 |
|
+£93.59 |
Portfolio sell value
(bid price-commission)
|
£51,182.37 |
(-48.4%)
|
+£348.06 |
| Potential profits |
£2,009.19 |
|
-£126.60 |
| Yr 9 Dividends |
£191.08 |
|
+£0 |
| Yr 9 Interest |
£2.46 |
|
+£0 |
| Yr 9 Profit from sales |
£31.44 |
|
+£31.44 |
| Yr 9 proj avg monthly profit |
£41.24 |
(0.7%) |
+£4.17 |
| Total Dividends |
£12,102.51 |
|
+£0 |
| Total Interest |
£4.39 |
|
+£0 |
| Total Profit from sales |
£17,329.97 |
|
+£31.44 |
| Average monthly cash profit |
£288.46 |
(4.9%) |
-£0.39 |
(Sold stocks profit + Dividends
- Fees / Months)
|
|
|
|
| Compound performance |
41% |
|
+0% |
I wanted to bed my PAGE:Page Group shares in my ISA but tried to be
clever and sold them rather than using the bed & ISA process.
Unfortunately I didn't know that AJ Bell won't allow you to transfer cash from
your dealing account to your ISA until a day after the settlement date - which
is next week! Meanwhile PAGE:Page Group were going up in value meaning
I wouldn't be able to get as many back. I decided to buy
JLP:Jubilee Metals instead, and it was these shares that dropped by 6%
after the placing news. I bought 16,072 at 6.72p costing £1,089.99.
I'm left with a bit of a dilemma, as I now have shares in my AJ Bell dealing
account that cost £6,154 but I only have £6,200 of my ISA allowance left for
this tax year. I do want to bed them into my ISA, but can't do all of them
unless I take a loss or risk trying to bed more than my allowance. I think
I'll play it safe and maybe bed my cheaper purchases if they get into profit.
Potential profits dropped because of the drop in OPTI:Optibiotix, and
none of my JLP:Jubilee Metals shares are in profit in this account
despite the 21% rise.
Heading very slowly in the right direction
Running parallel to the trend line but still below it.
The SIPP looks like this after week 420 overall and week 4 of year 9.
|
|
|
Weekly Change |
| Cash |
£642.80 |
|
+£85.09 |
| Portfolio cost |
£102,726.30 |
|
+£949.79 |
|
Portfolio sell value
(bid price - commission)
|
£56,819.55 |
(-44.7%)
|
-£270.15 |
| Potential profits |
£1,613.39 |
|
-£293.53 |
| Yr 9 Dividends |
£70.36 |
|
+£56.37 |
| Yr 9 Interest |
£0 |
|
+£0 |
| Yr 9 Profit from sales |
£2,662.56 |
|
+£663.11 |
| Yr 9 proj avg monthly profit |
£2,941.01 |
(51.6%) |
+£56.77 |
| Total Dividends |
£14,705.24 |
|
+£56.37 |
| Total Interest |
£5.93 |
|
+£0 |
| Total Profit from sales |
£13,498.46 |
|
+£663.11 |
| Average monthly cash profit |
£278.92 |
(4.9%) |
+£6.76 |
(Sold stocks profit + Dividends
- Fees / Months)
|
|
|
|
| Compound performance |
40% |
|
+1% |
A busy week! I got a £56 dividend from
PAF:Pan African Resources, but
unfortunately my holding has dropped in value by £136 as there seems to have
been a sell-off after the dividend. I sold another bunch of
OPTI:Optibiotix shares, off-loading 4,000 at 25.675p making £632.69
(160.4%) profit after buying them at 9.56p. I used the proceeds to buy 18,198
shares in
JLP:Jubilee Metals at 5.55p on the morning of the
announcement of the joint venture costing £1,021.94. These are already up 11%
and making £112 potential profit.
I also sold ANTO:Antofagasta as they are no longer in my top 30 magic
formula shares. I sold them for 1565.1693p making £30.43 (3.6%) profit. I
invested in the company I mentioned last week, buying 198 shares in
IPX:Impax Asset Management
at 503.0055p costing £1,005.90. These are 2% up and making £23 potential
profit in their first week.
I also had my monthly investment in AJB:AJ Bell and the curse struck
again. I bought 80 shares at 309.067p after they soared last week on brilliant
results, the day before news broke that they were going to have to pay more
interest on cash to their customers, at which point the share price tanked. I
couldn't believe it! Fortunately common sense prevailed, and the price crept
up during the week. Although it's just below what I bought them for, my
average is 289p so I'm up 3% on my overall holding.
Long term performance improved by £6 a month so my recent
OPTI:Optibiotix sales are helping drag this back to something vaguely
respectable. What's less respectable is the portfolio being 44% down on cost
price.
My strategy with the SIPP is to move to dividend playing shares, so the
JLP:Jubilee Metals holdings will be sold and moved to magic formula
shares if they get into decent profit. I'll probably sell some more
OPTI:Optibiotix too as I need to reduce the risk of my overweight
position given the serial disappointment they are serving up. I may change my
mind if we ever get good news on Sweetbiotix, but my faith is being severely
tested.
Although moving up, it's at the same pace as the cost so not a material
gain.
This demonstrates more accurately that we're worse off than last week, but
that does happen when I cash in profits.
The trading account looks like this after week 386 overall and week 22
of year 8.
|
|
|
Weekly Change |
| Cash |
£141.20 |
|
+£0 |
| Portfolio cost |
£1,935.11 |
|
+£0
|
Portfolio sell value
(bid price - commission)
|
£1,181.78 |
(-38.9%)
|
+£87.21 |
| Potential profits |
£0 |
|
+£0 |
| Year 8 Dividends |
£8.56 |
|
+£0 |
| Year 8 Interest |
£0 |
|
+£0 |
| Year 8 Profit |
£283.99 |
|
+£0 |
| Yr 8 proj avg monthly profit |
£57.62 |
(+35.7%) |
-£2.75 |
| Dividends |
£68.66 |
|
+£0 |
| Interest |
£0.03 |
|
+£0 |
| Profit from sales |
-£646.70 |
|
+£0 |
| Average monthly cash profit |
-£6.49 |
(-4.0%) |
+£0.02 |
(Sold stocks profit + Dividends
- Fees / Months)
|
A great week for
JLP:Jubilee Metals was dampened by a drop in
SBTX:SkinBioTherapeutix, with my new holding already 27% down in just a
few weeks. The curse of the trading account!
JLP is still 52% down so I
won't be selling them any time soon.
BARC:Barclays went up 2% but still
have a 12% deficit to make up before breaking even.
Nice!
Pretty much halved the gap to the trend line which is encouraging.
One week until the Christmas break. I think there's a good chance
JLP:Jubilee Metals will advance a little this week as they are getting
a lot of media attention, and people will realise the placing will accelerate
profits significantly. It's too late for OPTI:Optibiotix to give an
update so that could very well continue to slide and spoil the fun at the end
of the year.
At least after such an action-packed week I'll be up for a bit of a rest so
will be relieved if I don't need to buy or sell anything.
